Clinical Trials Directory

Trials / Unknown

UnknownNCT03892343

Effects of Renal Transplantation on Uraemic Cardiomyopathy

A Prospective Study of the Effects of Renal Transplantation on Uraemic Cardiomyopathy Using Magnetic Resonance Imaging.

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
University Hospital Birmingham NHS Foundation Trust · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

Chronic kidney disease (CKD) is associated with a high risk of death and morbidity due to cardiovascular disease. Much of this is caused by left ventricular disease characterised by abnormal muscle thickness and scaring. This process appears to start early in the course of CKD and causes heart failure and dangerous abnormal heart rhythms. Previous work suggests that the process may be reversible by kidney transplantation but almost all of the studies are small, retrospective and lack scientific rigour. Furthermore, they almost all use echocardiography, which is inaccurate in patients with CKD. The investigators plan to perform the first large, prospective, controlled, blind-analysed study using cardiac magnetic resonance imaging to determine whether CKD associated cardiomyopathy is reversed by kidney transplantation and if so, whether factors such as blood pressure and mediators of metabolic bone disease/fibrosis are important in effecting this change. Greater understanding of the mechanisms responsible for CKD associated cardiomyopathy could lead to future strategies and treatments to improve the high cardiovascular mortality associated with this condition.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCardiac MRICardiac Magnetic Resonance Imaging (Siemens Skyra 3T): will be performed using protocols and techniques already in use in our group. All CMR scan derived parameters will be analysed with the investigator blinded to treatment allocation as in previous studies.

Timeline

Start date
2018-12-05
Primary completion
2021-09-01
Completion
2021-09-01
First posted
2019-03-27
Last updated
2019-03-27

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03892343. Inclusion in this directory is not an endorsement.